Fifth-Generation Stereotactic Radiofrequency Surgery: Complete 14-Day Inpatient Service Guide for Refractory Brain & Psychiatric Disorders

Professor Wu Jingwen: Stereotactic Neurosurgery and Refractory Brain Disorders Specialist

Professor Wu Jingwen (吴景文) is a Chief Physician and clinical specialist in the Department of Functional Neurosurgery at Shanghai East Hospital (East Hospital Affiliated to Tongji University) in Shanghai, China. His clinical practice and academic research center on fifth-generation stereotactic radiofrequency surgery, neuronavigation, radiofrequency thermocoagulation, and deep brain stimulation (DBS), applied to severe, medication-resistant disorders of brain function within Shanghai's premier tertiary healthcare network (explore our Shanghai Hospital Network).

His work focuses on precision stereotactic neuromodulation for refractory schizophrenia, bipolar disorder, major depressive disorder, severe anxiety disorders, obsessive–compulsive disorder (OCD), and psychiatric disorders secondary to substance or alcohol use, alongside medication-refractory Parkinson’s disease and refractory epilepsy. Professor Wu also conducts clinical research on neurodegenerative diseases and post-stroke sequelae, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and residual deficits after ischemic stroke.

Clinical and Academic Focus

• fifth-generation stereotactic radiofrequency surgery;
• refractory schizophrenia and paranoid psychoses;
• treatment-resistant bipolar disorder and major depressive disorder;
• severe refractory anxiety disorders and obsessive–compulsive disorder (OCD);
• substance- and alcohol-induced refractory psychiatric disorders;
• medication-refractory Parkinson’s disease and intractable epilepsy;
• multimodal neuroimaging fusion (CT, 3.0T MRI, and DTI);
• intraoperative neurophysiological monitoring;
• translational stem-cell research for neurological conditions; and
• clinical investigations in Alzheimer’s disease, ALS, and post-stroke rehabilitation.

Academic Leadership and Research Contributions

Professor Wu has directed multiple major national-level research projects dedicated to minimally invasive surgical intervention for complex neurological conditions and translational stem-cell science. He has authored more than 100 academic papers in peer-reviewed journals and has received multiple national and provincial science and technology awards.

His clinical program at Shanghai East Hospital emphasizes individualized stereotactic planning, high operative safety, and reproducible clinical outcomes, ranking among the foremost functional neurosurgery units in China for refractory psychiatric and neurological neuromodulation.

Fifth-Generation Stereotactic Radiofrequency Surgery

Fifth-generation stereotactic radiofrequency surgery is an advanced, ultra-minimally invasive neurosurgical technique designed to modulate hyperactive or dysfunctional circuits implicated in refractory psychiatric and functional brain disorders. Open craniotomy is not performed. Access is established through a miniature 8 mm cranial burr hole.

Target planning relies on multimodal image fusion integrating computed tomography (CT), high-resolution magnetic resonance imaging (MRI), and diffusion tensor imaging (DTI). Under stereotactic guidance, a 2 mm radiofrequency electrode is advanced to predefined limbic nuclei or pathological circuit nodes. Controlled radiofrequency current produces a focal thermal lesion approximately 2 mm in diameter, interrupting abnormal circuits regulating emotion, thought, and impulse control.

Continuous intraoperative electrophysiological monitoring is performed throughout the procedure to verify physiological correspondence with the intended target and to preserve motor, language, and higher cognitive functions. The miniature cranial opening is closed using fine cosmetic subcuticular sutures within the hair-bearing scalp, leaving no conspicuous scar once hair regrowth occurs.

Strict Eligibility Criteria for Surgical Evaluation

Due to the irreversible nature of circuit lesioning, admission for surgical evaluation is governed by strict criteria. All of the following requirements must be verified before a patient is scheduled for formal inpatient evaluation:

• Age: 18 to 60 years, inclusive; male or female;
• Confirmed Diagnosis: a definitive clinical diagnosis of refractory schizophrenia, bipolar disorder, major depressive disorder, severe anxiety disorder, obsessive–compulsive disorder (OCD), psychiatric illness secondary to substance/alcohol use, or medication-refractory Parkinson’s disease or epilepsy;
• Disease Duration and Drug Resistance: illness duration of at least 3 years, with documented failure of at least three pharmacologically distinct medications given at adequate dosages for complete treatment courses;
• Persistent High-Risk Features: intractable symptoms such as persistent hallucinations, fixed delusions, acute manic agitation, impulsive aggression, or recurrent self-injurious and suicidal behaviors causing profound personal dysfunction or disruption of family and social order;
• Multidisciplinary Clearance: comprehensive multidisciplinary evaluation ruling out primary structural brain lesions (tumors, vascular malformations) and systemic organ failure, confirming tolerance for general anesthesia; and
• Voluntary Informed Consent: thorough understanding of potential surgical benefits, risks, and prognosis by the patient and family, evidenced by signed informed consent.

Not recommended: First-episode illness, patients who have not completed structured protocol-concordant medication trials, early disease dominated solely by mild or moderate depressive/anxiety symptoms, primary personality disorders, and pediatric patients under 18 years of age.

Absolute contraindications: Severe cardiac, pulmonary, hepatic, or renal failure; severe coagulopathy; active severe systemic infection; or inability to undergo general anesthesia.

Reported Clinical Efficacy and Recovery Timeline

In strictly screened refractory candidates, symptom alleviation is observed relatively soon after surgery. Intractable hallucinations, delusions, and violent or aggressive impulses frequently subside rapidly, facilitating the restoration of family relatedness and insight. Clinical response rates are reported at approximately 90% (individual outcomes vary and cannot be guaranteed).

Approximately 10% of patients may exhibit mild, transient symptom fluctuations within the first 3 months post-procedure. This does not indicate relapse, but reflects tissue healing and neuroplastic readjustment across neural circuits during recovery. Definitive appraisal of surgical efficacy requires follow-up of at least 1 year.

Standard 14-Day Inpatient Pathway

The standard clinical episode spans approximately 14 days, coordinated seamlessly through the CMCS Step-by-Step Patient Pathway. International families should plan for an additional 3 to 7 buffer days for travel and acclimatization in Shanghai:

• Preoperative Phase (Days 1–3): Diagnostic confirmation, comprehensive laboratory testing, specialized neurocognitive and psychiatric scale assessments, multimodal CT/MRI/DTI mapping, multidisciplinary board review, and hospital institutional approval;
• Operative Phase (Days 4–5): Individualized stereotactic radiofrequency procedure under general anesthesia with continuous neurophysiological monitoring, followed by cosmetic scalp closure;
• Postoperative Inpatient Phase (Days 6–14): Private single-room recovery with specialized nursing observation, follow-up neuroimaging, medical stabilization, and discharge evaluation; and
• Remote Follow-up: Structured remote consultations at 3 months, 6 months, and 1 year post-discharge to provide specialist guidance on maintenance medications. Local blood tests and imaging are recommended to be performed in the patient's home country and transmitted for review.

Estimated Medical Fees and Service Inclusions (~RMB 140,000)

The estimated medical expenditure for a standard 14-day inpatient admission is approximately RMB 140,000 (~USD 19,500), covering standard perioperative healthcare with no hidden medical charges:

• Included in standard package: private single-room bed fee, preoperative specialized brain function assessment, routine inpatient nursing, complete diagnostic panels (imaging and laboratory tests), general anesthesia, stereotactic radiofrequency procedure fee, cosmetic wound closure, routine perioperative medications, standard surgical consumables, post-discharge remote follow-up guidance, official Chinese medical invoices/itemized receipts, English Medical Summary for insurance submission, and cross-border bank transfer documentation.
• Excluded / Patient responsibility: emergency resuscitation and treatment in the event of unexpected surgical complications (incidence ~1%), bed and nursing fees exceeding 14 days, evaluation and treatment of pre-existing non-psychiatric comorbid medical conditions, external third-party specialist consultation fees, post-discharge outpatient medications and tests in the home country, Chinese Medical Visa (M-Visa) fees and processing, extensive clinical document translation, personal bedside caregiving/attendants, flights, local accommodation, meals, personal expenditures, and direct overseas insurance settlement.

Who May Consider a Consultation?

• patients with schizophrenia or schizoaffective disorder whose auditory hallucinations or delusions have resisted multiple antipsychotic regimens;
• patients with severe bipolar disorder or major depressive disorder who have failed multiple classes of antidepressants, mood stabilizers, and physical therapies;
• patients with disabling, treatment-refractory obsessive–compulsive disorder (OCD);
• patients with refractory psychiatric conditions secondary to substance or alcohol dependence;
• patients with medication-refractory Parkinson’s disease experiencing disabling motor fluctuations;
• patients with intractable epilepsy being evaluated for stereotactic intervention; or
• families seeking an expert remote medical consultation and second opinion regarding stereotactic neuromodulation eligibility in China.

Medical Records to Prepare

• detailed psychiatric and neurological history, including age of onset, clinical progression, and specific symptom manifestations;
• complete chronological medication history, detailing drug names, maximum doses, duration of trials, adverse effects, and therapeutic responses;
• recent brain MRI and CT imaging records in original DICOM digital format;
• neuropsychiatric assessment reports and standardized rating scales (e.g., PANSS, HAM-D, Y-BOCS, or MMSE);
• routine laboratory panels (complete blood count, liver and kidney function, coagulation profile, and infectious disease markers);
• electroencephalogram (EEG) reports if evaluating epilepsy or seizure-like events; and
• documentation of previous hospitalizations, neuromodulation (ECT, rTMS), or surgical procedures.

Planning an International Consultation & Travel Notices

Acute suicidal crisis, severe unmanageable physical agitation, or acute medical decompensation requires immediate emergency care in the patient’s home country prior to international travel.

For stable candidates, remote record assessment requires written physician authorization and patient or guardian consent. Preliminary review does not constitute a surgical guarantee; final procedural eligibility requires in-person multidisciplinary psychiatric and neurosurgical evaluation upon admission.

Patients must hold a valid passport and obtain an appropriate visa; for detailed visa category and document requirements, refer to our China Medical Visa Guide (S1/S2/M Visa) before travelling. Prolonged air travel is not advised immediately post-surgery, and the surgical team will provide individualized clearance on safe flight timing. Routine psychiatric medications must continue under the supervision of the patient’s local physician after returning home.

How CMCS Can Assist

CMCS – China Medical Concierge Shanghai is an independent medical concierge and health management company, not a hospital. Through our structured CMCS 7-Stage Concierge Journey, we assist international patients with organizing and translating medical records, identifying appropriate specialists, requesting appointment availability, arranging professional medical interpretation, coordinating in-hospital care, and planning medical travel in Shanghai.

Access to Professor Wu Jingwen, remote review, stereotactic radiofrequency surgery, or inpatient admission is subject to doctor and hospital approval. CMCS does not guarantee appointments, procedure eligibility, symptom resolution, or clinical outcomes.

• Email: contract@medicalsh.com
• WhatsApp: Contact us on WhatsApp
• Website: www.medicalsh.com

Important Note

Doctor titles, clinical roles, surgical techniques, hospital admission policies, and appointment arrangements may change. This profile is based on the supplied verified research document and is for general information only. It does not replace multidisciplinary assessment by a qualified neurosurgical and psychiatric team.